AAAAAA

   
Results: 1-13 |
Results: 13

Authors: GULER N BALTALI E ALTINDAG K OZISIK Y TEKUZMAN G FIRAT D
Citation: N. Guler et al., PACLITAXEL IN THE SALVAGE TREATMENT OF METASTATIC BREAST-CARCINOMA, Annals of oncology, 9, 1998, pp. 144-144

Authors: YALCIN S TEKUZMAN G BALTALI E OZISIK Y BARISTA I ZENGIN N
Citation: S. Yalcin et al., 5-HT3 RECEPTOR ANTAGONISTS IN PROPHYLAXIS OF ACUTE AND DELAYED EMESISINDUCED BY MODERATELY EMETOGENIC SINGLE DAY CHEMOTHERAPY, Annals of oncology, 9, 1998, pp. 718-718

Authors: YALCIN S KARS A OZISIK Y TEKUZMAN G OZYILKAN O CELIK I BARISTA I GULLU I GULER N BALTALI E FIRAT D
Citation: S. Yalcin et al., VB-CHEP CHEMOTHERAPY REGIMEN FOR AGGRESSIVE NON-HODGKINS-LYMPHOMAS, European journal of haematology, 61(4), 1998, pp. 261-265

Authors: KOC Y AKPEK G KANSU E KARS A TEKUZMAN G BALTALI E GULER N BARISTA I GULLU I OZISIK Y FIRAT D
Citation: Y. Koc et al., BOLUS AND CONTINUOUS-INFUSION MITOXANTRONE IN NEWLY-DIAGNOSED ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OF 2 CONSECUTIVE PHASE-II CLINICAL-STUDIES, Cancer investigation, 16(6), 1998, pp. 355-365

Authors: YALCIN S GULLU I BARISTA J TEKUZMAN G OZISIK Y CELIK I KARS A
Citation: S. Yalcin et al., TREATMENT OF ADVANCED REFRACTORY SARCOMAS WITH IFOSFAMIDE AND ETOPOSIDE COMBINATION CHEMOTHERAPY, Cancer investigation, 16(5), 1998, pp. 297-302

Authors: ZENGIN N KARS A OZISIK Y CANPINAR H TURKER A RUACAN S
Citation: N. Zengin et al., ALEUKEMIC LEUKEMIA-CUTIS IN A PATIENT WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of the American Academy of Dermatology, 38(4), 1998, pp. 620-621

Authors: KARS A CELIK I KANSU E TEKUZMAN G OZISIK Y GULER N BARISTA I GULLU I YALCIN S ALTUNDAG K ZENGIN N TURKER A HAYRAN M BALTALT E FIRAT D
Citation: A. Kars et al., MAINTENANCE THERAPY WITH ALPHA-INTERFERON FOLLOWING FIRST-LINE VAD INMULTIPLE-MYELOMA, European journal of haematology, 59(2), 1997, pp. 100-104

Authors: BARISTA I BALTALI E GULLU IH GULER N CELIK I SARACBASI O TEKUZMAN G KARS A OZISIK Y RUACAN S ATAHAN IL FIRAT D
Citation: I. Barista et al., FACTORS INFLUENCING THE DISTRIBUTION OF METASTASES AND SURVIVAL IN METASTATIC BREAST-CARCINOMA, American journal of clinical oncology, 19(6), 1996, pp. 569-573

Authors: BAYRAKTAR Y BALKANCI F KAYHAN B UZUNALIMOGLU B GOKOZ A OZISIK Y GURAKAR A VANTHIEL DH FIRAT D
Citation: Y. Bayraktar et al., A COMPARISON OF CHEMOEMBOLIZATION WITH CONVENTIONAL CHEMOTHERAPY AND SYMPTOMATIC TREATMENT IN CIRRHOTIC-PATIENTS WITH HEPATOCELLULAR-CARCINOMA, Hepato-gastroenterology, 43(9), 1996, pp. 681-687

Authors: KARS A CELIK I KANSU E OZISIK Y GULER N BARISTA I GULLU IH YALCIN S ALTUNDAG K ZENGIN N TEKUZMAN G BALTALI E FIRAT D
Citation: A. Kars et al., VINCRISTINE, ADRIAMYCIN AND DEXAMETHASONE CHEMOTHERAPY WITH OR WITHOUT INTERFERON-ALPHA-2B MAINTENANCE IN MULTIPLE-MYELOMA, Blood, 88(10), 1996, pp. 3609-3609

Authors: GULER N BALTALI E KARS A OZISIK Y ENUNLU T TEKUZMAN G OZYILKAN O ONAT D GULLU I BARISTA I FIRAT D
Citation: N. Guler et al., CMF OR CMF-IIIA BREAST-CARCINOMA(RT AS ADJUVANT THERAPY IN PATIENTS WITH STAGE I), European journal of cancer, 31A, 1995, pp. 70-70

Authors: BARISTA I TEKUZMAN G GULLU I BALTALI E KARS A OZISIK Y GULER N CELIK I ATAHAN IL FIRAT D
Citation: I. Barista et al., NON-HODGKINS-LYMPHOMAS OF THE TONSIL - A RETROSPECTIVE ANALYSIS OF 28PATIENTS WITH PRIMARY TONSILLARY LYMPHOMA, Tumori, 81(4), 1995, pp. 234-237

Authors: BARISTA I TEKUZMAN G FIRAT D BALTALI E KANSU E KARS A OZISIK Y RUACAN S UZUNALIMOGLU B KARAAGAOGLU E
Citation: I. Barista et al., NON-HODGKINS-LYMPHOMAS IN TURKEY - 18 YEARS EXPERIENCE AT THE HACETTEPE-UNIVERSITY, Japanese journal of cancer research, 85(12), 1994, pp. 1200-1207
Risultati: 1-13 |